Compare Dropbox Inc (DBX) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dropbox Inc vs Neurocrine Biosciences Inc — how do they compare? Dropbox Inc trades at $33.8 (market cap $7.41B), while Neurocrine Biosciences Inc trades at $152.04 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 2.2× Dropbox Inc's market cap, and Dropbox Inc is trading nearer its 52-week high, Neurocrine Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| DBX | NBIX | |
|---|---|---|
Market Cap | $7.41B | $16.46B |
Sector | Technology | Health |
52-Week High | $35.00 | $185.50 |
52-Week Low | $22.06 | $123.10 |
Enterprise Value | $10.27B | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dropbox Inc
Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
